首页> 美国卫生研究院文献>Case Reports in Oncology >Primary Burkitts Lymphoma Presenting as a Rapidly Growing Thyroid Mass
【2h】

Primary Burkitts Lymphoma Presenting as a Rapidly Growing Thyroid Mass

机译:原发性伯基特氏淋巴瘤呈快速增长的甲状腺肿块

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 31-year-old male patient presented with a rapidly growing neck mass with normal thyroid function tests. Ultrasonography showed thyroidal expansion, a hypoechoic nodule that completely filled the right lobe, and 2 hypoechoic lymphadenopathies in the right jugulodigastric chain. The patient underwent right total and left subtotal thyroidectomy, following the diagnosis of nodular goiter; however, postoperative histopathological evaluation demonstrated primary Burkitt's lymphoma of the thyroid gland. The tumor was staged as stage 1, and R-hyper-CVAD protocol (rituximab, hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone) was administered. The protocol was changed to R-CHOP after 4 cycles due to recurrent grade III/IV cytopenias and febrile neutropenia. The PET-CT scans performed after chemotherapy and at the 6-month follow-up were normal. In summary, we reported a case with a diagnosis of Burkitt's lymphoma, which is a rare type of primary thyroid lymphoma.
机译:一名31岁的男性患者,颈部肿块迅速增长,甲状腺功能检查正常。超声检查显示甲状腺肿大,一个低回声结节完全充满了右叶,在右胃窦链中有2个低回声淋巴腺病。诊断为结节性甲状腺肿后,患者应进行右全甲状腺切除术和左全甲状腺切除术。然而,术后组织病理学评估显示原发性甲状腺伯基特氏淋巴瘤。肿瘤分期为1期,并给予R-hyper-CVAD方案(利妥昔单抗,超分割环磷酰胺,长春新碱,阿霉素和地塞米松)。由于复发的III / IV级血细胞减少和发热性中性粒细胞减少症,该方案在4个周期后更改为R-CHOP。化疗后和随访6个月时进行的PET-CT扫描正常。总之,我们报告了一例诊断为Burkitt淋巴瘤的病例,这是一种罕见的原发性甲状腺淋巴瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号